Doctors, AMA, its president Dr Omar Korshid have made claims for the Pfizer/BioNTech vaccine that BioNTech has not made : False advertising, and grounds for insurance cover exclusion?

 by Ganesh Sahathevan 



A number of doctors, their trade union the Australian Medical Association, and its president Dr Omar Korshid, have taken to main stream and social media to convince the populace to be COVID vaccinated.

They invariably make claims about vaccine efficacy and safety, and it appears make claims that even BioNTech , the producer of the Pfizer vaccine, does not make. Worse, the risk factors listed by BioNTech seem to have been swept aside. In doing so they are not very different from the political classes (see story below).

However, unlike the PM and other politicians AMA members rely on insurance cover to protect themselves from liability. Making claims about  any medication, including COVID vaccines, that even the manufacturer does not make, and concealing risks the manufacturer makes public, are quite likely grounds for insurance cover exclusion. 


TO BE READ WITH 


Monday, August 30, 2021

BioNTech's SEC disclosed risk factors include " limited regulatory experience with mRNA immunotherapies": Despite the warning, governments worldwide have insisted that they have the skills to evaluate, at record speed, the use of the Pfizer/BioNTech COVID vaccine

 by Ganesh Sahathevan 




More from BioNTech's SEC disclosures. Again, from the 2020 Annual Report: 
"...mRNA drug development has substantial clinical development and regulatory risks due to limited regulatory experience with mRNA immunotherapies...".

This writer cannot recall any government authority admitting to the risk of limited experience with mRNA immunotherapies.
Instead governments everywhere have approved and begun supplying the Pfizer/BioNTech vaccine to their people, 

The Australian Government, in typical fashion, via its ABC media service, has even launched a media campaign where it asserts that "no corners have been cut" in manufacturing and approving any of the COVID vaccines.

TO BE READ WITH 





Saturday, August 28, 2021

Pfizer/ BioNTech warned investors that the durability of the immune response of its COVID vaccine had " not yet been demonstrated in clinical trials"-US SEC disclosure by BioNTech calls for investigation into Scott Morrison, Daniel Andrews, and Gladys Berekilian's promotion of Pfizer/ BioNTech

 by Ganesh Sahathevan 


Prime Minister Scott Morrison had his Covid jab in February 2021.



The developer of the Pfizer COVID vaccine, Comirnaty,
BioNTech SE has lodged documents at the US Securities and Exchange Commission (SEC), pursuant to US securities disclosure laws.

The documents include BioNTech SE's annual report for the year ended 31 December 2021 It includes this statement which is among a range of cautionary statements that the company is bound by law to alert investors to:

"......the durability of (the) immune response generated by our COVID-19 vaccine....has not yet been demonstrated in clinical trials........."

This is an important issue for investors for a vaccine with limited durability is not going to sell well, if at all.  Taxpayers would not be willing to spend billions on a vaccine that provides protection for only a relatively short  amount of time. 

However, in Australia, we have in fact seen the Prime Minister, Scott Morrison,  and the state leaders in particular  Premier Daniel Andrews of Victoria  and Premier Gladys Berekilian of NSW  promoting  the  Pfizer/ BioNTech COVID vaccine, as if it were guaranteed to provide life long protection. In the process they have expanded billions. Taxpayers are entitled to an explanation.

END 

Comments

Popular posts from this blog

"Not new or worthy of consideration" : WA Corruption & Crime Commissioner confirms but dismisses Anne Azza Aly 's referring queries about PAVE, her work to Malaysia

If Damien Tudehope's COVID hotel quarantine fee statements are correct, SLHD revenue reported in financial statements signed by former CEO Teresa Anderson is overstated, and false

Strata managers' aversion to contact with tenants can leave strata managers exposed to personal liability